Radiosensitization by BRAF inhibitor therapy-mechanism and frequency of toxicity in melanoma patients

Annals of Oncology : Official Journal of the European Society for Medical Oncology
M HechtL Heinzerling

Abstract

Recent evidence suggests that ionizing radiation may be associated with unexpected side-effects in melanoma patients treated with concomitant BRAF inhibitors. A large multicenter analysis was carried out to generate reliable safety data and elucidate the mechanism. A total of 161 melanoma patients from 11 European skin cancer centers were evaluated for acute and late toxicity, of whom 70 consecutive patients received 86 series of radiotherapy with concomitant BRAF inhibitor therapy. To further characterize and quantify a possible radiosensitization by BRAF inhibitors, blood samples of 35 melanoma patients were used for individual radiosensitivity testing by fluorescence in situ hybridization of chromosomal breaks after ex vivo irradiation. With radiotherapy and concomitant BRAF inhibitor therapy the rate of acute radiodermatitis ≥2° was 36% and follicular cystic proliferation was seen in 13% of all radiotherapies. Non-skin toxicities included hearing disorders (4%) and dysphagia (2%). Following whole-brain radiotherapy, rates of radiodermatitis ≥2° were 44% and 8% (P < 0.001) for patients with and without BRAF inhibitor therapy, respectively. Concomitant treatment with vemurafenib induced acute radiodermatitis ≥2° more frequent...Continue Reading

References

Jan 29, 2005·Cancer Genetics and Cytogenetics·Ulrike KellerLuitpold Distel
Nov 23, 2006·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Luitpold V R DistelGerhard G Grabenbauer
Feb 8, 2011·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Maria J SambadeJaniel M Shields
Jun 7, 2011·The New England Journal of Medicine·Paul B ChapmanUNKNOWN BRIM-3 Study Group
Oct 5, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·P L MatteiA B Kimball
Oct 23, 2012·Expert Review of Neurotherapeutics·Ekokobe FonkemEric T Wong
Mar 27, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Imke SatzgerRalf Gutzmer
May 8, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Christopher J AnkerKenneth F Grossmann
Sep 26, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Natalia RompotiLisa Zimmer
Dec 4, 2013·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Reinhard DummerJeannine D Rinderknecht
Jan 29, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·James J HardingMario E Lacouture
Apr 20, 2014·Melanoma Research·Andrea ForschnerFriedegund Meier

❮ Previous
Next ❯

Citations

Nov 5, 2015·Expert Opinion on Investigational Drugs·Matthias PreusserPeter Birner
Feb 3, 2016·Critical Reviews in Oncology/hematology·Magali FortUNKNOWN TRONE (Transatlantic Radiation Oncology NEtwork)
Sep 20, 2015·Journal of Neuro-oncology·Tina DasguptaDaphne A Haas-Kogan
Oct 10, 2015·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·Björn SchulzePanagiotis Balermpas
Dec 1, 2015·Future Oncology·Sebastian ZahnreichHeinz Schmidberger
Sep 5, 2015·Current Treatment Options in Oncology·Silvina B PuglieseBernice Y Kwong
Apr 18, 2016·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Lars HofmannLucie M Heinzerling
May 22, 2016·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·R RauschenbergF Meier
Nov 11, 2016·Acta Oncologica·Mathilde Weisz EjlsmarkLars Bastholt
Oct 21, 2017·Expert Opinion on Drug Safety·Sarah KnispelElisabeth Livingstone
Oct 19, 2017·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A V TalletY M Kirova
Feb 17, 2018·Therapeutic Advances in Medical Oncology·Rodica Di Lorenzo, Manmeet S Ahluwalia
May 1, 2020·Current Treatment Options in Oncology·Anupam Rishi, Hsiang-Hsuan Michael Yu
Aug 27, 2016·International Cancer Conference Journal·Kazuhito UekiMasaki Kokubo
May 8, 2016·BJR Case Reports·Daniela AlterioBarbara Alicja Jereczek-Fossa
Jan 26, 2016·Current Opinion in Oncology·Simone M GoldingerPaul Nathan
Oct 11, 2017·Neuro-oncology·Alicia M Zukas, David Schiff
May 11, 2019·Dermatology Research and Practice·Susanne J RogersStephan B Bodis
May 26, 2018·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·A BoadaJ Malvehy
Dec 2, 2020·Pediatric Blood & Cancer·Samuel Bergeron GravelDerek S Tsang
Dec 11, 2020·International Journal of Molecular Sciences·Felix BürkelLuitpold Distel
Aug 11, 2020·Cancer radiothérapie : journal de la Société française de radiothérapie oncologique·E JouglarS Supiot
Jan 5, 2021·Current Opinion in Oncology·Alvaro MoreiraLucie Heinzerling
Oct 26, 2020·BMC Neurology·Jenny StritzelbergerLuitpold Distel

❮ Previous
Next ❯

Related Concepts

Related Feeds

Auditory Perception

Auditory perception is the ability to receive and interpret information attained by the ears. Here is the latest research on factors and underlying mechanisms that influence auditory perception.

Related Papers

Cancer radiothérapie : journal de la Société française de radiothérapie oncologique
A DucassouV Sibaud
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Trish PulvirentiWei Wang
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]
Ricarda MertenS Semrau
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Natalia RompotiL Zimmer
© 2021 Meta ULC. All rights reserved